Connection

VALERAE O LEWIS to Time Factors

This is a "connection" page, showing publications VALERAE O LEWIS has written about Time Factors.
Connection Strength

0.207
  1. Radiation therapy is associated with fewer recurrences in mesenchymal chondrosarcoma. Clin Orthop Relat Res. 2014 Mar; 472(3):856-64.
    View in: PubMed
    Score: 0.043
  2. Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma? Clin Orthop Relat Res. 2014 Mar; 472(3):983-9.
    View in: PubMed
    Score: 0.043
  3. A long femoral stem is not always required in hip arthroplasty for patients with proximal femur metastases. Clin Orthop Relat Res. 2013 May; 471(5):1622-7.
    View in: PubMed
    Score: 0.040
  4. Do Early Results of Proximal Humeral Allograft-Prosthetic Composite Reconstructions Persist at 5-year Followup? Clin Orthop Relat Res. 2019 04; 477(4):758-765.
    View in: PubMed
    Score: 0.015
  5. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas? Clin Orthop Relat Res. 2015 Nov; 473(11):3604-11.
    View in: PubMed
    Score: 0.012
  6. Operative management of metastatic melanoma in bone may require en bloc resection of disease. Clin Orthop Relat Res. 2014 Oct; 472(10):3196-203.
    View in: PubMed
    Score: 0.011
  7. What are the factors that affect survival and relapse after local recurrence of osteosarcoma? Clin Orthop Relat Res. 2014 Oct; 472(10):3188-95.
    View in: PubMed
    Score: 0.011
  8. Can regional anesthesia and analgesia prolong cancer survival after orthopaedic oncologic surgery? Clin Orthop Relat Res. 2014 May; 472(5):1434-41.
    View in: PubMed
    Score: 0.011
  9. Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus. Cancer. 2009 Aug 15; 115(16):3767-73.
    View in: PubMed
    Score: 0.008
  10. Functional outcome following endoprosthetic reconstruction of the proximal humerus. J Shoulder Elbow Surg. 2009 Sep-Oct; 18(5):705-10.
    View in: PubMed
    Score: 0.008
  11. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res. 2002 Nov; 8(11):3584-91.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.